FDA accepts application for Salix Pharmaceuticals' new bowel cleansing preparation — 4 key notes

The FDA approved Salix Pharmaceutical's new drug application for Plenvu, a lower-volume polyethylene glycol-based bowel preparation developed for bowel cleansing.

Here's what you should know:

1. Plenvu additionally focuses on preparing the ascending colon.

2. If approved, Plenvu will tout the lowest total volume of solution for a bowel cleanser.

3. Salix expects an FDA decision in the first quarter of fiscal year 2018.

4. Salix is a subsidiary of Valeant Pharmaceuticals.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast